Immediate Impact
12 standout
Citing Papers
The interaction of innate immune and adaptive immune system
2024 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Works of Yasmin Karimi being referenced
P1214: SUBCUTANEOUS EPCORITAMAB + R-CHOP FOR FIRST-LINE TREATMENT OF PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA: PHASE 1/2 UPDATE
2022
Phase 2 Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Plamotamab Combined with Tafasitamab (Tafa) + Lenalidomide (Len) Vs Tafa+Len in Relapsed or Refractory DLBCL
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Yasmin Karimi | 76 | 89 | 19 | 45 | 35 | 123 | |
| Romana Idress | 57 | 86 | 15 | 24 | 25 | 203 | |
| Charlotte Syrykh | 74 | 70 | 15 | 33 | 23 | 192 | |
| Catalina Falo | 42 | 103 | 7 | 27 | 27 | 175 | |
| Casey Liveringhouse | 44 | 96 | 12 | 31 | 25 | 177 | |
| Hope Rugo | 70 | 110 | 14 | 30 | 35 | 210 | |
| Leo Meriranta | 121 | 79 | 33 | 11 | 22 | 156 | |
| Dooreh Kim | 38 | 113 | 5 | 29 | 36 | 243 | |
| Weiping Liu | 69 | 54 | 15 | 29 | 31 | 129 | |
| Yu‐Min Yeh | 39 | 77 | 14 | 19 | 34 | 192 | |
| Sarah Reinke | 88 | 67 | 20 | 7 | 22 | 144 |
All Works
Login with ORCID to disown or claim papers
Loading papers...